151 related articles for article (PubMed ID: 35248552)
1. Preclinical evidence of the effect of quercetin on diabetic nephropathy: A meta-analysis of animal studies.
Feng X; Bu F; Huang L; Xu W; Wang W; Wu Q
Eur J Pharmacol; 2022 Apr; 921():174868. PubMed ID: 35248552
[TBL] [Abstract][Full Text] [Related]
2. The effect of quercetin on diabetic nephropathy (DN): a systematic review and meta-analysis of animal studies.
Hu T; Yue J; Tang Q; Cheng KW; Chen F; Peng M; Zhou Q; Wang M
Food Funct; 2022 May; 13(9):4789-4803. PubMed ID: 35416188
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of ginsenosides on diabetic nephropathy: A systematical review and meta-analysis of preclinical evidence.
Chen XM; Lin GX; Wang X; Ma HY; Wang RS; Wang SM; Tang D
J Ethnopharmacol; 2023 Feb; 302(Pt A):115860. PubMed ID: 36341813
[TBL] [Abstract][Full Text] [Related]
4. Effective dose/duration of natural flavonoid quercetin for treatment of diabetic nephropathy: A systematic review and meta-analysis of rodent data.
Li Z; Deng H; Guo X; Yan S; Lu C; Zhao Z; Feng X; Li Q; Wang J; Zeng J; Ma X
Phytomedicine; 2022 Oct; 105():154348. PubMed ID: 35908521
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.
Hu HC; Lei YH; Zhang WH; Luo XQ
Front Pharmacol; 2022; 13():841818. PubMed ID: 35355720
[No Abstract] [Full Text] [Related]
6. The potential therapeutic effects of Trifolium alexandrinum extract, hesperetin and quercetin against diabetic nephropathy via attenuation of oxidative stress, inflammation, GSK-3β and apoptosis in male rats.
Abdou HM; Abd Elkader HAE
Chem Biol Interact; 2022 Jan; 352():109781. PubMed ID: 34922902
[TBL] [Abstract][Full Text] [Related]
7. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats.
Anjaneyulu M; Chopra K
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):244-8. PubMed ID: 15053821
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evidence for quercetin against inflammatory bowel disease: a meta-analysis and systematic review.
Hu S; Zhao M; Li W; Wei P; Liu Q; Chen S; Zeng J; Ma X; Tang J
Inflammopharmacology; 2022 Dec; 30(6):2035-2050. PubMed ID: 36227442
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
Elbe H; Vardi N; Esrefoglu M; Ates B; Yologlu S; Taskapan C
Hum Exp Toxicol; 2015 Jan; 34(1):100-13. PubMed ID: 24812155
[TBL] [Abstract][Full Text] [Related]
10. Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis.
Luo Q; Cai Y; Zhao Q; Jiang Y; Tian L; Liu Y; Liu WJ
J Diabetes Res; 2022; 2022():3770417. PubMed ID: 35746917
[TBL] [Abstract][Full Text] [Related]
11. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of quercetin in rheumatoid arthritis models: meta-analysis and systematic review of animal studies.
Liu X; Tao T; Yao H; Zheng H; Wang F; Gao Y
Inflammopharmacology; 2023 Aug; 31(4):1629-1645. PubMed ID: 37150762
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of berberine in diabetic nephropathy: A systematic review and meta-analysis revealing the mechanism of action.
Hu S; Wang J; Liu E; Zhang X; Xiang J; Li W; Wei P; Zeng J; Zhang Y; Ma X
Pharmacol Res; 2022 Nov; 185():106481. PubMed ID: 36195307
[TBL] [Abstract][Full Text] [Related]
14. Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats.
Tang L; Li K; Zhang Y; Li H; Li A; Xu Y; Wei B
Sci Rep; 2020 Feb; 10(1):2440. PubMed ID: 32051470
[TBL] [Abstract][Full Text] [Related]
15. A Significant Association Between Rhein and Diabetic Nephropathy in Animals: A Systematic Review and Meta-Analysis.
Hu HC; Zheng LT; Yin HY; Tao Y; Luo XQ; Wei KS; Yin LP
Front Pharmacol; 2019; 10():1473. PubMed ID: 31920660
[No Abstract] [Full Text] [Related]
16. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy.
Yaribeygi H; Mohammadi MT; Rezaee R; Sahebkar A
J Cell Biochem; 2018 Sep; 119(9):7458-7469. PubMed ID: 29761900
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Effects of Quercetin in Association with Moderate Exercise Training in Improving Streptozotocin-Induced Aortic Tissue Injuries.
Chis IC; Coseriu A; Simedrea R; Oros A; Nagy AL; Clichici S
Molecules; 2015 Dec; 20(12):21770-86. PubMed ID: 26690102
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy.
Gomes IB; Porto ML; Santos MC; Campagnaro BP; Pereira TM; Meyrelles SS; Vasquez EC
Lipids Health Dis; 2014 Dec; 13():184. PubMed ID: 25481305
[TBL] [Abstract][Full Text] [Related]
19. P-Coumaric acid alleviates experimental diabetic nephropathy through modulation of Toll like receptor-4 in rats.
Zabad OM; Samra YA; Eissa LA
Life Sci; 2019 Dec; 238():116965. PubMed ID: 31629762
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
Jin D; Yu M; Li X; Wang X
J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
